Luminex Corporation develops, manufactures and sells biological testing technologies and products with applications throughout the life sciences and diagnostic industries. Its Multi-Analyte Profiling (xMAP) technology allows analysis of up to 100 bioassays from a sample volume, typically a single drop of fluid, by reading biological tests on the surface of microscopic polystyrene beads called microspheres. xMAP technology is used within segments of the life sciences industry, which includes the fields of drug discovery and development, clinical diagnostics, genetic analysis, bio-defense, protein analysis and biomedical research. Its business is organized into two reportable segments: the technology segment and the assay segment.
(Source: 10-K) – less–ZoomInfo